Correlation of CDKN2A Status with MTAP: Association with Molecular Subtype and Clinical Outcomes of Muscle Invasive Urothelial Carcinoma

被引:0
|
作者
Oberc, Alexander [1 ]
Olkhov-Mitsel, Ekaterina [2 ]
Slodkowska, Elzbieta [3 ]
Craddock, Kenneth [3 ]
Downes, Michelle [2 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
789
引用
收藏
页码:S782 / S783
页数:2
相关论文
共 43 条
  • [31] Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder
    Oliver Patschan
    Shahrokh F. Shariat
    Daher C. Chade
    Pierre I. Karakiewicz
    Raheela Ashfaq
    Yair Lotan
    Kristina Hotakainen
    Ulf-Håkan Stenman
    Anders Bjartell
    World Journal of Urology, 2012, 30 : 785 - 794
  • [32] Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder
    Patschan, Oliver
    Shariat, Shahrokh F.
    Chade, Daher C.
    Karakiewicz, Pierre I.
    Ashfaq, Raheela
    Lotan, Yair
    Hotakainen, Kristina
    Stenman, Ulf-Hakan
    Bjartell, Anders
    WORLD JOURNAL OF UROLOGY, 2012, 30 (06) : 785 - 794
  • [33] Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical Research
    Necchi, Andrea
    Lo Vullo, Salvatore
    Giannatempo, Patrizia
    Raggi, Daniele
    Perrone, Federica
    Nicolai, Nicola
    Catanzaro, Mario
    Biasoni, Davide
    Torelli, Tullio
    Piva, Luigi
    Stagni, Silvia
    Salvioni, Roberto
    Mariani, Luigi
    Colecchia, Maurizio
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : E403 - E410
  • [34] Does Separate Detrusor Muscle Sampling at Initial TURBT Improve the Adequacy of Pathological Staging and Clinical Outcomes in Patients with Invasive Grade 3 Urothelial Cell Carcinoma?
    Dalleywater, W. J.
    Dormer, J.
    JOURNAL OF PATHOLOGY, 2016, 240 : 39 - 39
  • [35] The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast
    Choi, Yoomi
    Kim, Eun Joo
    Seol, Hyesil
    Lee, Hee Eun
    Jang, Mi Jung
    Kim, Sun Mi
    Kim, Jee Hyun
    Kim, Sung-Won
    Choe, Gheeyoung
    Park, So Yeon
    HUMAN PATHOLOGY, 2012, 43 (01) : 48 - 55
  • [36] Correlation of B-cell lymphoma 2 immunoexpression in invasive carcinoma of breast, no special type with hormone receptor status, proliferation index, and molecular subtypes
    Azmat, Henna
    Faridi, Javeria
    Habib, Hafiz Muhammad
    Bugti, Umair Jan
    Sheikh, Ahmareen Khalid
    Riaz, Syeda Kiran
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (09) : S313 - S319
  • [37] What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review
    Veskimae, Erik
    Linares Espinos, Estefania
    Bruins, Harman Maxim
    Yuan, Yuhong
    Sylvester, Richard
    Kamat, Ashish M.
    Shariat, Sharokh F.
    Witjes, J. Alfred
    Comperat, Eva M.
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (06): : 625 - 642
  • [38] Comparative analysis of p53, p21 and bcl-2 expression in muscle invasive urothelial carcinoma of the bladder: Correlation with progression-free survival.
    Jimenez, RE
    Oskanian, P
    Tiguert, R
    Sakr, W
    Li, Y
    Wood, D
    Pontes, J
    Sarkar, F
    Grignon, D
    LABORATORY INVESTIGATION, 1999, 79 (01) : 98A - 98A
  • [39] Correlation of hormonal receptor status, Ki-67 and cerbB2 expression with prognosis, invasive recurrence and therapeutic outcomes in ductal carcinoma in situ of the breast
    Poulakaki, N.
    Makris, G. M.
    Evagelinakis, N.
    Bafaloukos, D.
    Siristatidis, C.
    Chrelias, C. H.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S122 - S122
  • [40] Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target
    Go, Heounjeong
    Kim, Pil-Jong
    Jeon, Yoon Kyung
    Cho, Yong Mee
    Kim, Kyungeun
    Park, Bong-Hee
    Ku, Ja Yoon
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (14) : 1937 - 1945